IGEA Pharma NV
F:3B5

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
F:3B5
Watchlist
Price: 16.791 EUR -3.07% Market Closed
Market Cap: 10.6m EUR

Relative Value

3B5 price has not been updated for more than 5 years. This may indicate that the stock has been delisted.
3B5 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of 3B5.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

3B5 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.3
vs History
vs Industry
Median 3Y
0.4
Median 5Y
0.4
Industry
22.5
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-12.9
Industry
14.4
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-13.4
Industry
21.4
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-11.2
Industry
11.9
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-11.2
Industry
16.8
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-14.3
Industry
14.5
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-14.3
Industry
18.6
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
1.9

Multiples Across Competitors

3B5 Competitors Multiples
IGEA Pharma NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
IGEA Pharma NV
F:3B5
505.5k EUR 0 0.4 -2.9 -2.9
US
Abbott Laboratories
NYSE:ABT
218.3B USD 5 15.6 19.9 27.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
209.1B USD 21.8 76.1 58.4 71.2
US
Boston Scientific Corp
NYSE:BSX
144.5B USD 7.5 51.8 30.2 41.1
US
Stryker Corp
NYSE:SYK
140.1B USD 5.7 47.6 23.2 28.1
IE
Medtronic PLC
NYSE:MDT
125B USD 3.6 26.2 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.2 24.5 13.7 19.4
US
Becton Dickinson and Co
NYSE:BDX
58B USD 2.7 34.6 12.7 21.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.9B USD 13.7 55.4 39.8 44.1
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD 8.4 36.1 25.8 28.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.5B USD 1.9 17.8 13.2 16
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NL
IGEA Pharma NV
F:3B5
Average EV/EBITDA: 25.2
Negative Multiple: -2.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.9
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.4
26%
2.2
US
Boston Scientific Corp
NYSE:BSX
30.2
22%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
13.7
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.7
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.8
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.2
10%
1.3